Cargando…
Regulation of cell death in cancer—possible implications for immunotherapy
Since most anticancer therapies including immunotherapy trigger programmed cell death in cancer cells, defective cell death programs can lead to treatment resistance and tumor immune escape. Therefore, evasion of programmed cell death may provide one possible explanation as to why cancer immunothera...
Autor principal: | Fulda, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578186/ https://www.ncbi.nlm.nih.gov/pubmed/23441073 http://dx.doi.org/10.3389/fonc.2013.00029 |
Ejemplares similares
-
Oncogenic RAS Mutants Confer Resistance of RMS13 Rhabdomyosarcoma Cells to Oxidative Stress-Induced Ferroptotic Cell Death
por: Schott, Christina, et al.
Publicado: (2015) -
Immunogenic Cell Death-Relevant Damage-Associated Molecular Patterns and Sensing Receptors in Triple-Negative Breast Cancer Molecular Subtypes and Implications for Immunotherapy
por: Xu, Ming, et al.
Publicado: (2022) -
Autophagy in Cancer Therapy
por: Fulda, Simone
Publicado: (2017) -
The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer
por: Zhao, Rongling, et al.
Publicado: (2023) -
How to target apoptosis signaling pathways for the treatment of pediatric cancers
por: Fulda, Simone
Publicado: (2013)